K
Kazuma Ogawa
Researcher at Kanazawa University
Publications - 134
Citations - 2150
Kazuma Ogawa is an academic researcher from Kanazawa University. The author has contributed to research in topics: Biodistribution & Chemistry. The author has an hindex of 24, co-authored 120 publications receiving 1862 citations. Previous affiliations of Kazuma Ogawa include University of Texas MD Anderson Cancer Center & Yamagata University.
Papers
More filters
Journal ArticleDOI
Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors
Hirofumi Hanaoka,Takahiro Mukai,Takahiro Mukai,Hirokazu Tamamura,Hirokazu Tamamura,Tomohiko Mori,Seigo Ishino,Kazuma Ogawa,Yasuhiko Iida,Ryuichiro Doi,Nobutaka Fujii,Hideo Saji +11 more
TL;DR: Findings suggested that 111In-DTPA-Ac-TZ14011 would be a potential agent for the imaging of CXCR4 expression in metastatic tumors in vivo.
Journal ArticleDOI
Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT
Hsin Hsien Yeh,Kazuma Ogawa,Kazuma Ogawa,Julius Balatoni,Uday Mukhapadhyay,Asutosh Pal,Carlos Gonzalez-Lepera,Aleksandr Shavrin,Suren Soghomonyan,Leo Ii. Flores,Daniel Young,Andrei Volgin,Amer Najjar,Victor Krasnykh,William P. Tong,Mian M. Alauddin,Juri G. Gelovani +16 more
TL;DR: PET with [18F]F-PEG6-IPQA could be used for the selection of NSCLC patients for individualized therapy with small molecular inhibitors of EGFR kinase that are currently used in the clinic and have a similar structure.
Journal Article
Development of a Novel 99mTc-Chelate–Conjugated Bisphosphonate with High Affinity for Bone as a Bone Scintigraphic Agent
TL;DR: In this paper, a bifunctional radiopharmaceutical called 99mTc-chelate−conjugated bisphosphonate with high affinity for bone and rapid clearance from blood was developed.
Journal ArticleDOI
Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides
Hiromichi Akizawa,Yasushi Arano,Masaki Mifune,Akimasa Iwado,Yutaka Saito,Takahiro Mukai,Tomoya Uehara,Masahiro Ono,Yasushi Fujioka,Kazuma Ogawa,Yoshiaki Kiso,Hideo Saji +11 more
TL;DR: An increase of negative charges in peptide molecules may constitute a strategy for designing 111In-DTPA-conjugated LMW peptides with low renal radioactivity levels.
Conjugated Bisphosphonate with High Affinity for Bone as a Bone Scintigraphic Agent
TL;DR: A novel (99m)Tc-chelate-conjugated bisphosphonate with high affinity for bone and rapid clearance from blood is developed, based on the concept of bifunctional radiopharmaceuticals, that holds great potential for bone scintigraphy.